当前位置: 首页 > 期刊 > 《中国医学创新》 > 2014年第6期 > 正文
编号:12707223
人宫颈癌组织中survivin的表达与临床分析(4)
http://www.100md.com 2014年2月25日 丁玉梅等
第1页

    参见附件。

     [6] Hendruschk S, Wiedemuth R, Aigner A, et al.RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo[J].Neuro Oncol, 2011, 13(10): 1074-1089.

    [7] Shailendra K.Beyond pancreatic carcinoma: The close relationship between survivin levels and prognosis in systemic malignancies[J].World J Clin Oncol, 2012, 3(5): 80-81.

    [8] Erkanli S, Bolat F, Kayaselcuk F, et al.COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma[J].Gynecol Oncol, 2007, 104(2):320-325.

    [9] Liguang Z, Peishu L, Hongluan M, et al.Survivin expression in ovarian cancer[J].Exponcol, 2007, 29(2): 121-125.

    [10] Branca I, Giorgi C, Santini D, et al.Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirusand a predictor of virus clearance and prognosis in cervical cancer[J].Am J clin Pathol, 2005, 124(1):113-121.

    [11] Bache M, Holzapfel D, Kappler M, et al.Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy[J]. Gynecol Oncol, 2007, 104(2):139-144.

    [12] Lee J P,Chang K H,Han J H,et al.Survivin,a novel anti-apoptosis inhibitor,expression in uterine cervical cancer and relationship with prognostic factors[J].Int J Gynecol Cancer, 2005, 15(1):113-119.

    [13]卢洪胜,甘梅富,张艳,等.宫颈癌前病变及宫颈癌组织中Survivin 和P16INK4A及P53表达的研究[J].中华肿瘤防治,2009,16(11):810-813.

    (收稿日期:2013-09-22) (本文编辑:黄新珍)

您现在查看是摘要介绍页,详见PDF附件